Finance logo
right-img
Home
Featured News
Finance News
Banking News
Home
| Mylan CEO to answer for EpiPen price hikes
Mylan CEO to answer for EpiPen price hikes
September 22, 2016
The CEO of Mylan takes center stage Wednesday to answer questions before the House Oversight Committee about why the company jacked up the price of its EpiPen by 400%.
Read more at:
http://rss.cnn.com/~r/rss/money_topstories/~3/OKVmqyX7uHU/index.html
Other News
Stericycle Inc. (SRCL) Forecasted to Post Q1 2017 Earnings of $1.12 Per Share
Q1 2017 EPS Estimates for Matrix Service Co. (MTRX) Cut by KeyCorp
Leon Cooperman charged with insider trading
U.S. gives Airbus green light to sell planes to Iran
Site Created by finaceandbankingnewsnow.com